Sculptiva expands its professional aesthetic portfolio with Sculptiva PDLLA + HA, a hybrid collagen biostimulator developed to combine progressive collagen regeneration with the hydrating properties of Hyaluronic Acid.
The formulation contains 170 mg Poly-D,L-Lactic Acid (PDLLA) and 30 mg Hyaluronic Acid (HA) in one 200 mg vial. The product is designed for professional use in selected facial and body areas according to clinical assessment and treatment protocol.
Dual-action approach
PDLLA microparticles are designed to support the skin's natural collagen regeneration process over time, while Hyaluronic Acid contributes immediate hydration after treatment. This combination is intended to support progressive improvement in skin quality, firmness and natural-looking volume.
Key product specifications
- 170 mg PDLLA + 30 mg HA
- 1 vial × 200 mg
- Particle size: 30–60 μm
- Recommended injection depth: subcutaneous tissue / deep dermis
- Expected duration: up to 18–24 months*
- Reconstitution: 3 mL sterile water for injection or normal saline
*Duration may vary depending on individual patient characteristics and treatment protocol.
For full product information, technical specifications and treatment guidance, visit the Sculptiva PDLLA + HA product page.